Your browser does not support iframes.
Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
MAP Pharmaceuticals, Inc.
(NQ:
MAPP
)
24.98
USD
UNCHANGED
Last Price
/ Updated:
8:10 PM EST, Mar 1, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
-
Bid (Size)
24.98 (191900)
Ask (Size)
24.99 (1000)
Prev. Close
24.98
Today's Range
24.98 - 24.98
52wk Range
11.11 - 25.03
Shares Outstanding
35,287,096
Dividend Yield
N/A
Top News
More News
65.4% Return Seen to Date on SmarTrend MAP Pharmaceuticals Call (MAPP)
March 04, 2013
from
Comtex SmarTrend® News Briefs
UPDATE: Wedbush Downgrades MAP Pharmaceuticals to Neutral, Reiterates $25 PT on Likely Acquisition
March 01, 2013
In a report published Friday, Wedbush downgraded its rating on MAP Pharmaceuticals (NASDAQ: MAPP ) from Outperform to Neutral, and reiterated its $25.00 price target. Wedbush noted, “Allergan...
Read More
category
Benzinga
,
Downgrades
,
Wedbush
, and 3 more.
from
Latest Articles from Benzinga.com
More News
Read More
Wedbush Downgrades MAP Pharmaceuticals (MAPP) to Neutral
March 01, 2013
from
StreetInsider.com News Articles
Allergan, Inc. Announces Expiration of Tender Offer for All Outstanding Shares of MAP Pharmaceuticals, Inc. and Intent to Exercise Top-Up Option to Effect a Short-Form Merger
March 01, 2013
from
Business Wire News Releases
Short Interest Jumps 38.3% For MAPP
February 28, 2013
category
Stocks
from
Market News Video
Uptrend Call Working As MAP Pharmaceuticals Stock Rises 65.1% (MAPP)
February 23, 2013
from
Comtex SmarTrend® News Briefs
Free Research Report on Noble Energy, Inc., MAP Pharmaceuticals, Inc., Darden Restaurants, Inc., Canadian National Railway Co. and Sensata Techologies Holdings NV
February 19, 2013
from
Marketwired News Releases
Uptrend Call Working As MAP Pharmaceuticals Stock Rises 64.9% (MAPP)
February 15, 2013
from
Comtex SmarTrend® News Briefs
MAP Pharmaceuticals: The Winning Streak Continues (MAPP)
February 11, 2013
from
Comtex SmarTrend® News Briefs
MAP Pharmaceuticals Has Returned 64.8% Since SmarTrend Recommendation (MAPP)
February 07, 2013
from
Comtex SmarTrend® News Briefs
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.